BioCentury
ARTICLE | Company News

GlycoDesign, Inflazyme deal

April 14, 2003 7:00 AM UTC

IZP will acquire GD in a stock deal worth about C$12.8 million ($8.7 million) based on a 10-day trailing stock price for IZP of C$0.58. Under the deal, IZP will issue 22 million shares for all of GD’s...